Back to Search
Start Over
Transient Anti-Phospholipid Antibodies in Two Patients With COVID-19
- Source :
- Cureus
- Publication Year :
- 2021
- Publisher :
- Cureus, 2021.
-
Abstract
- We report two cases of coronavirus disease 2019 (COVID-19) in patients who developed pulmonary embolism and transient anti-phospholipid antibodies. At the time of presentation with acute pulmonary embolism, both patients had leukocytosis and increased levels of anti-cardiolipin antibodies, which resolved at testing 12 weeks after initial presentation. Studying cases of pulmonary embolism and increased anti-phospholipid antibodies in the context of COVID-19 could be one of the factors for elucidating the possible connection between severe acute respiratory syndrome coronavirus 2 infection, anti-phospholipid antibodies, and thrombosis.
- Subjects :
- medicine.medical_specialty
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
venous thromboembolism
anti-phospholipid antibodies
Context (language use)
030204 cardiovascular system & hematology
b-cell proliferation
Gastroenterology
Allergy/Immunology
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Internal Medicine
Leukocytosis
biology
business.industry
General Engineering
Hematology
medicine.disease
Thrombosis
Pulmonary embolism
Anti phospholipid antibodies
covid-19
biology.protein
lipids (amino acids, peptides, and proteins)
Antibody
medicine.symptom
business
030217 neurology & neurosurgery
Subjects
Details
- Language :
- English
- ISSN :
- 21688184
- Volume :
- 13
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Cureus
- Accession number :
- edsair.doi.dedup.....5032b871c3dde97113b4824bbe874325